Who is the CEO of Radiopharm Theranostics Limited?

The CEO of Radiopharm Theranostics Limited is Riccardo Canevari.

What industry does Radiopharm Theranostics Limited belong to?

Radiopharm Theranostics Limited operates in the Biotechnology industry within the Healthcare sector.

Where is Radiopharm Theranostics Limited headquartered?

Radiopharm Theranostics Limited is headquartered at 62 Lygon Street, Carlton, VIC, 3053, AU.

What is the IPO date of Radiopharm Theranostics Limited?

Radiopharm Theranostics Limited went public on November 24, 2021.

How many employees does Radiopharm Theranostics Limited have?

The total number of employees at Radiopharm Theranostics Limited is disclosed periodically in the company's annual financial reports.

Radiopharm Theranostics Limited

RAD.AX•ASX

Healthcare

Biotechnology

A$0.03

A$0.003(12.50%)

Radiopharm Theranostics Limited (RAD.AX) Company Profile & Overview

Explore Radiopharm Theranostics Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Radiopharm Theranostics Limited (RAD.AX) Company Profile & Overview

Radiopharm Theranostics Limited develops radiopharmaceutical products for diagnostic and therapeutic uses. The company was incorporated in 2021 and is based in Carlton, Australia.

SectorHealthcare

IndustryBiotechnology

CEORiccardo Canevari

Contact Information

https://www.radiopharmtheranostics.com

61 3 9824 5254

62 Lygon Street, Carlton, VIC, 3053

Company Facts

IPO DateNov 24, 2021

CountryAU

Actively Trading

Frequently Asked Questions

;